Xiangyu Medical Co Ltd. Stock Analysis 688626.SS

Xiangyu Medical Co., Ltd. engages in the research, development, production, and sale of rehabilitation medical equipment. The company is headquartered in Anyang, Henan and currently employs 2,195 full-time employees. The company went IPO on 2021-03-31. The firm's main products include extracorporeal shock wave therapy devices, piezoelectric shock wave therapy devices, ultrasound therapy devices, pelvic floor functional magnetic stimulation therapy devices, electromyography biofeedback training systems, red light therapy devices. The firm's products cover rehabilitation physiotherapy, rehabilitation training, rehabilitation nursing, rehabilitation aids, rehabilitation assessment, traditional Chinese medicine diagnosis and treatment, and health preservation, and can be used to treat musculoskeletal pain, delayed fractures and avascular necrosis of the femoral head, cervical spondylosis, lumbar disc herniation, degenerative osteoarthritis, and other conditions. The firm mainly conducts its business in the domestic and overseas markets.